Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Long-Term Investments (2018 - 2025)

Historic Long-Term Investments for Ascendis Pharma A (ASND) over the last 8 years, with Q4 2025 value amounting to $37.9 million.

  • Ascendis Pharma A's Long-Term Investments rose 16102.75% to $37.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $37.9 million, marking a year-over-year increase of 16102.75%. This contributed to the annual value of $36.8 million for FY2025, which is 15339.34% up from last year.
  • According to the latest figures from Q4 2025, Ascendis Pharma A's Long-Term Investments is $37.9 million, which was up 16102.75% from $33.1 million recorded in Q3 2025.
  • Over the past 5 years, Ascendis Pharma A's Long-Term Investments peaked at $43.9 million during Q4 2021, and registered a low of -$12.3 million during Q1 2021.
  • Over the past 5 years, Ascendis Pharma A's median Long-Term Investments value was $23.6 million (recorded in 2023), while the average stood at $21.4 million.
  • In the last 5 years, Ascendis Pharma A's Long-Term Investments plummeted by 18886.09% in 2021 and then surged by 41988.82% in 2022.
  • Over the past 5 years, Ascendis Pharma A's Long-Term Investments (Quarter) stood at $43.9 million in 2021, then tumbled by 46.66% to $23.4 million in 2022, then plummeted by 66.54% to $7.8 million in 2023, then soared by 85.32% to $14.5 million in 2024, then surged by 161.03% to $37.9 million in 2025.
  • Its Long-Term Investments was $37.9 million in Q4 2025, compared to $33.1 million in Q3 2025 and $39.5 million in Q2 2025.